These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 29571859)
1. Plasma citrulline levels are increased in patients with multiple sclerosis. Vande Vyver M; Beelen R; De Keyser J; Nagels G; Van Binst AM; Verborgh C; D'haeseleer M J Neurol Sci; 2018 Apr; 387():174-178. PubMed ID: 29571859 [TBL] [Abstract][Full Text] [Related]
2. Changes in expression profiles of internal jugular vein wall and plasma protein levels in multiple sclerosis. Marchetti G; Ziliotto N; Meneghetti S; Baroni M; Lunghi B; Menegatti E; Pedriali M; Salvi F; Bartolomei I; Straudi S; Manfredini F; Voltan R; Basaglia N; Mascoli F; Zamboni P; Bernardi F Mol Med; 2018 Aug; 24(1):42. PubMed ID: 30134823 [TBL] [Abstract][Full Text] [Related]
3. In vivo characterization of cortical and white matter neuroaxonal pathology in early multiple sclerosis. Granberg T; Fan Q; Treaba CA; Ouellette R; Herranz E; Mangeat G; Louapre C; Cohen-Adad J; Klawiter EC; Sloane JA; Mainero C Brain; 2017 Nov; 140(11):2912-2926. PubMed ID: 29053798 [TBL] [Abstract][Full Text] [Related]
4. Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker. Kolind S; Seddigh A; Combes A; Russell-Schulz B; Tam R; Yogendrakumar V; Deoni S; Sibtain NA; Traboulsee A; Williams SC; Barker GJ; Brex PA Neuroimage Clin; 2015; 9():574-80. PubMed ID: 26594633 [TBL] [Abstract][Full Text] [Related]
5. Myelin Basic Protein Citrullination in Multiple Sclerosis: A Potential Therapeutic Target for the Pathology. Yang L; Tan D; Piao H Neurochem Res; 2016 Aug; 41(8):1845-56. PubMed ID: 27097548 [TBL] [Abstract][Full Text] [Related]
6. CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis. Rejdak K; Eikelenboom MJ; Petzold A; Thompson EJ; Stelmasiak Z; Lazeron RH; Barkhof F; Polman CH; Uitdehaag BM; Giovannoni G Neurology; 2004 Oct; 63(8):1439-45. PubMed ID: 15505162 [TBL] [Abstract][Full Text] [Related]
7. Mitoxantrone: a review of its use in multiple sclerosis. Scott LJ; Figgitt DP CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110 [TBL] [Abstract][Full Text] [Related]
8. CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human, Proof-of-Concept Dose-Escalation Study. Belogurov A; Zakharov K; Lomakin Y; Surkov K; Avtushenko S; Kruglyakov P; Smirnov I; Makshakov G; Lockshin C; Gregoriadis G; Genkin D; Gabibov A; Evdoshenko E Neurotherapeutics; 2016 Oct; 13(4):895-904. PubMed ID: 27324388 [TBL] [Abstract][Full Text] [Related]
9. Immunologic Effects of Metformin and Pioglitazone Treatment on Metabolic Syndrome and Multiple Sclerosis. Negrotto L; Farez MF; Correale J JAMA Neurol; 2016 May; 73(5):520-8. PubMed ID: 26953870 [TBL] [Abstract][Full Text] [Related]
10. Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis Severity. Regev K; Healy BC; Khalid F; Paul A; Chu R; Tauhid S; Tummala S; Diaz-Cruz C; Raheja R; Mazzola MA; von Glehn F; Kivisakk P; Dupuy SL; Kim G; Chitnis T; Weiner HL; Gandhi R; Bakshi R JAMA Neurol; 2017 Mar; 74(3):275-285. PubMed ID: 28114622 [TBL] [Abstract][Full Text] [Related]
11. A longitudinal uncontrolled study of cerebral gray matter volume in patients receiving natalizumab for multiple sclerosis. Khalid F; Tauhid S; Chua AS; Healy BC; Stankiewicz JM; Weiner HL; Bakshi R Int J Neurosci; 2017 May; 127(5):396-403. PubMed ID: 27143245 [TBL] [Abstract][Full Text] [Related]
12. Citrulline-containing myelin basic protein is recognized by T-cell lines derived from multiple sclerosis patients and healthy individuals. Martin R; Whitaker JN; Rhame L; Goodin RR; McFarland HF Neurology; 1994 Jan; 44(1):123-9. PubMed ID: 7507225 [TBL] [Abstract][Full Text] [Related]
13. Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis. Calabrese M; De Stefano N; Atzori M; Bernardi V; Mattisi I; Barachino L; Morra A; Rinaldi L; Romualdi C; Perini P; Battistin L; Gallo P Arch Neurol; 2007 Oct; 64(10):1416-22. PubMed ID: 17923625 [TBL] [Abstract][Full Text] [Related]
14. Quantitative evaluation of cerebral white matter in patients with multiple sclerosis using multicomponent T2 mapping. Baranovicova E; Mlynarik V; Kantorova E; Hnilicova P; Dobrota D Neurol Res; 2016 May; 38(5):389-96. PubMed ID: 27078709 [TBL] [Abstract][Full Text] [Related]
15. Increased cortical curvature reflects white matter atrophy in individual patients with early multiple sclerosis. Deppe M; Marinell J; Krämer J; Duning T; Ruck T; Simon OJ; Zipp F; Wiendl H; Meuth SG Neuroimage Clin; 2014; 6():475-87. PubMed ID: 25610761 [TBL] [Abstract][Full Text] [Related]
16. HMGB1 as a potential new marker of disease activity in patients with multiple sclerosis. Bucova M; Majernikova B; Durmanova V; Cudrakova D; Gmitterova K; Lisa I; Klimova E; Kluckova K; Buc M Neurol Sci; 2020 Mar; 41(3):599-604. PubMed ID: 31728855 [TBL] [Abstract][Full Text] [Related]